Expression of fibroblast growth factor receptors 1-4 in human chronic tympanic membrane perforation

Akinobu Kakigi1, Aya Uchida, Masahiko Nishimura

  • 1Department of Otolaryngology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan. kakigi-tky@umin.ac.jp

Abstract

Insights

Fibroblast growth factor receptors (FGFRs) 1-4 are present in chronic tympanic membrane perforations. Their expression suggests that basic fibroblast growth factor (bFGF) agents may aid in myringoplasty healing.

Area of Science:

  • Otolaryngology
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Chronic tympanic membrane (TM) perforations pose challenges in hearing restoration.
  • Fibroblast growth factors (FGFs) and their receptors (FGFRs) are crucial in tissue repair and regeneration.
  • Understanding FGFR expression in TM perforations can inform therapeutic strategies.

Purpose of the Study:

  • To investigate the presence and localization of fibroblast growth factor receptors (FGFRs) 1-4 in human chronic tympanic membrane perforations.
  • To assess the potential role of FGFRs in the healing process of TM perforations.

Main Methods:

  • Human chronic TM perforation samples were obtained during myringoplasty surgery.
  • Samples were fixed and embedded for immunohistochemical analysis.
  • Polyclonal antibodies against FGFRs 1-4 were used to detect receptor expression.

Main Results:

  • Fibroblast growth factor receptors (FGFRs) 1-4 were detected in the epidermal and mucosal layers of chronic TM perforations.
  • Strong expression was noted in the epidermal layer, with weaker expression in the mucosal layer.

Conclusions:

  • The study confirms the presence of FGFRs 1-4 in human chronic TM perforations.
  • The observed expression patterns suggest that FGFRs play a role in TM perforation healing.
  • These findings support the potential clinical utility of basic fibroblast growth factor (bFGF) agents in myringoplasty procedures.